DOI:
10.1055/s-00000105
Zentralblatt für Gynäkologie
LinksClose Window
References
Slamon DJ, Leyland-Jones D, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J, Norton L.
Use of Chemotherapy plus a monoclonal Antibody against HER2 for metastatic Breast Cancer that overexpresses HER2.
N Engl J Med 2001; 344: 783-792
We do not assume any responsibility for the contents of the web pages of other providers.